Overview

Mixed-mode Chromatography Resin Market is poised to value USD 239 million by 2028 end at a CAGR of 15.7% during the forecast period 2022 to 2028.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Mixed-mode Chromatography Resin Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Mixed-mode Chromatography Resin Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Mixed-mode Chromatography Resin Market are :

• GE Healthcare Lifesciences
• Merck KGaA
• Tosoh Corp
• Purolite Corp
• Danaher Corp
• Bio-Rad Labs​​​​​
(Note: The list of the major players will be updated with the latest market scenario and trends)

Mixed-mode Chromatography Resin Market Segmentation:

By Type
• Ion Exchange-Hydrophobic Type
• Hydroxyapatite Type
• Others

By Application
• Antibodies Production 
• Vaccine Production 
• Non-antibody Proteins
• Antibody-drug conjugate
• Separation of low molecular weight impurities

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share  
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the Mixed-mode Chromatography Resin Market by type, by application and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record and evaluate competitive landscape mapping- product launches, technological advan Terumoents, mergers and expansions

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization services offered are free of charge with purchase of any license of the report.
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
         1.1. Objectives of the Study 
         1.2. Market Definition 
         1.3. Market Scope 
                1.3.1. Years Considered for the Study
                1.3.2. Market Covered
         1.4. Currency 
         1.5. Limitations 
         1.6. Stakeholders 
 2.  Research Methodology 
         2.1. Research Data 
                2.1.1. Secondary Data
                           2.1.1.1. Key Data from Secondary Sources
                2.1.2. Primary Data
                           2.1.2.1. Key Data from Primary Sources
         2.2. Market Size Estimation 
         2.3. Market Breakdown and Data Triangulation 
         2.4. Assumptions for the Study  
3. Executive Summary
         3.1. Market Outlook
         3.2. Segment Outlook
         3.3. Competitive Insights
4. Mixed-mode Chromatography Resin Market Variables, Trends & Scope
         4.1. Market Lineage Outlook
         4.2. Penetration and Growth Prospect Mapping
         4.3. Industry Value Chain Analysis
         4.4. Cost Analysis Breakdown
         4.5. Technology Overview
         4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances
5. Mixed-mode Chromatography Resin Market Overview
         5.1. Market Dynamics
                 5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus of Mixed-mode Chromatography Resin Companies on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                 5.1.2. Market Restraint Analysis
                            5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
                 5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Mixed-mode Chromatography Resin Market Analysis Tools
         6.1. Industry Analysis - Porter’s
                 6.1.1. Supplier Power
                 6.1.2. Buyer Power
                 6.1.3. Substitution Threat
                 6.1.4. Threat from New Entrants
                 6.1.5. Competitive Rivalry
         6.2. Pestel Analysis
                 6.2.1. Political Landscape
                 6.2.2. Environmental Landscape
                 6.2.3. Social Landscape
                 6.2.4. Technology Landscape
                 6.2.5. Legal Landscape
         6.3. Major Deals And Strategic Alliances Analysis
                 6.3.1. Joint Ventures
                 6.3.2. Mergers and Acquisitions
                 6.3.3. Licensing and Partnership
                 6.3.4. Technology Collaborations
                 6.3.5. Strategic Divestments
         6.4. Market Entry Strategies
         6.5. Case Studies
7. Mixed-mode Chromatography Resin Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million)
         7.1. Ion Exchange-Hydrophobic Type
         7.2. Hydroxyapatite Type
         7.3. Others
8. Mixed-mode Chromatography Resin Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)
         8.1. Antibodies Production 
         8.2. Vaccine Production
         8.3. Non-Antibody Proteins
         8.4. Antibody-drug conjugate
         8.5. Separation of low molecular weight impurities
9. North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
         9.1. Introduction
         9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                 9.2.1. U.S.A
                 9.2.2. Canada
                 9.2.3. Mexico
         9.3. Market Size (USD Million) Forecast for North America 2022-2028 
10. Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
         10.1. Introduction
         10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                   10.2.1. Brazil
                   10.2.2. Venezuela
                   10.2.3. Argentina
                   10.2.4. Rest of Latin America
         10.3. Market Size (USD Million) Forecast for Latin America 2022-2028  
11. Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
         11.1. Introduction
         11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                   11.2.1. Germany
                   11.2.2. U.K
                   11.2.3. France
                   11.2.4. Italy
                   11.2.5. Spain
                   11.2.6. Russia
                   11.2.7. Poland
                   11.2.8. Rest of Europe
         11.3. Market Size (USD Million) Forecast for Europe 2022-2028
12. Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
         12.1. Introduction
         12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                   12.2.1. Japan
                   12.2.2. China
                   12.2.3. India
                   12.2.4. Australia and New Zealand
                   12.2.5. ASEAN
                   12.2.6. Rest of Asia Pacific
         12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
13. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
         13.1. Introduction
         13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                   13.2.1. GCC
                   13.2.2. Israel
                   13.2.3. South Africa
                   13.2.4. Rest of MEA
         13.3. Market Size (USD Million) Forecast for MEA 2022-2028
14. Market Share Analysis and Competitive Landscape   
         14.1. Global Landscape - Key Players, Revenue and Presence
         14.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
         14.3. Global Emerging Companies
         14.4. North America - Market Share Analysis and Key Regional Players
         14.5. Europe - Market Share Analysis and Key Regional Players
         14.6. Asia Pacific - Market Share Analysis and Key Regional Players
         14.7. Global Key Player - Growth Matrix
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
         15.1. GE Healthcare Lifesciences
                   15.1.1. Company Overview
                   15.1.2. Product Portfolio
                   15.1.3. SWOT Analysis
                   15.1.4. Financial Overview
                   15.1.5. Strategic Overview
         15.2. Merck KGaA
                   15.2.1. Company Overview
                   15.2.2. Product Portfolio
                   15.2.3. SWOT Analysis
                   15.2.4. Financial Overview
                   15.2.5. Strategic Overview
         15.3. Tosoh Corp
                   15.3.1. Company Overview
                   15.3.2. Product Portfolio
                   15.3.3. SWOT Analysis
                   15.3.4. Financial Overview
                   15.3.5. Strategic Overview
         15.4. Purolite Corp
                   15.4.1. Company Overview
                   15.4.2. Product Portfolio
                   15.4.3. SWOT Analysis
                   15.4.4. Financial Overview
                   15.4.5. Strategic Overview
         15.5. Danaher Corp
                   15.5.1. Company Overview
                   15.5.2. Product Portfolio
                   15.5.3. SWOT Analysis
                   15.5.4. Financial Overview
                   15.5.5. Strategic Overview
         15.6. Bio-Rad Labs​​​​​
                   15.6.1. Company Overview
                   15.6.2. Product Portfolio
                   15.6.3. SWOT Analysis
                   15.6.4. Financial Overview
                   15.6.5. Strategic Overview
16. Pre and Post COVID-19 Impact
    16.1. Positive influence on the healthcare industry
    16.2. The financial disruption of the manufacturing sector
    16.3. Impact of COVID-19 on emerging companies
    16.4. Significant mandates in the healthcare regulations initiated by administrations
    16.5. The overall economic slowdown of the developing and developed nations
17. FutureWise SME Key Takeaway Points for Client

Tables

Figures